FDA NDC Directory · JSON-LD · Markdown

NYSTATIN

NDC 81033-015 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerKesin Pharma Corporation
Marketing categoryAbbreviated NDA (generic) · App ANDA062832
Dosage form / routeSUSPENSION · ORAL
Active ingredientsNYSTATIN (100000 U/mL)
Marketing started20200814
Package count2

External sources

Source: openFDA. Public-domain (CC0).